BETAHISTINE EG 8 mg, tablet 30 tablets
Active ingredients: Betahistine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BETAHISTINE EG 8 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Aug 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65970533CIP73865628CIP133400938656282Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DICHLORHYDRATE DE BÉTAHISTINEcomprimé | 8 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.